The MedTech and Life Sciences Geopolitical Landscape

MedTech and Life Sciences profitability is being reshaped by more than competition—it is increasingly driven by global geopolitical forces. From tariffs and centralized procurement in China to U.S. drug pricing reforms, policy shifts are now central to strategy and earnings. This report examines both long-standing and emerging pressures and outlines how enterprises can adapt to protect margins and sustain growth.

Please provide your work email to Download this exclusive and original content from N28Tech. You can also reach the author at hello@n28tech.com